Home

Gisela Schwab

CIK 1213140 · Pres, Prod Dev & Med Aff & CMO · last filed 2021-07-28

Gisela Schwab is a Pres, Prod Dev & Med Aff & CMO who has filed 84 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider exercised options covering $168.0K of EXEL on Jul 28, 2021. Across all open-market trades the lifetime net is −$36.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $39.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$39.18M

Companies

2

Total Filings

84

Lifetime Open-Market Net

-$36.55M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EXEL Pres, Prod Dev & Med Aff & CMO 703,958 $55.65 $39.18M -$36.55M 82 2021-07-28
GENOCEA BIOSCIENCES, INC. (GNCA) Delisted Director — $0.00 — $0 2 2021-07-02

Recent Filings

84 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-07-28 EXEL Exer (M) +40,000 $168.0K EDGAR
2021-07-23 EXEL Exer (M) +35,000 $147.0K EDGAR
2021-07-02 GENOCEA BIOSCIENCES, INC. (GNCA) Delisted Grant (A) — $0 EDGAR
2021-05-14 EXEL Mixed — -$2.35M EDGAR
2021-04-28 EXEL Mixed — -$1.17M EDGAR
2021-04-02 EXEL Mixed — -$1.06M EDGAR
2021-03-05 EXEL Grant (A) +72,885 $0 EDGAR
2021-02-19 EXEL Mixed — -$2.07M EDGAR
2021-02-17 EXEL Tax (F) −2,858 -$62.6K EDGAR
2021-02-05 EXEL Mixed +66,056 -$338.0K EDGAR
Showing 1–10 of 84
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.